StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.40+0.01 (+0.16%)

Close on Nov 18, 2026Market cap $242.26MP/E –Yield –

Lifecore Biomedical pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Lifecore Biomedical's pe ratio was 82.6× on Dec 31, 2024, against 14.4× a year earlier. Over the last 5 years it ranged from 13.3× to 82.6×, with a median of 22.5×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Dec 31, 202482.6×+45.1
2019Jun 28, 201937.5×+23.0
2018Dec 31, 201814.4×−21.6
2017Dec 29, 201736.0×+13.7
2016Mar 31, 201622.3×−0.4
2015Dec 31, 201522.8×+0.8
2014Dec 31, 201421.9×+8.0
2013Dec 31, 201313.9×−2.2
2012Dec 31, 201216.1×−23.3
2011Dec 30, 201139.4×−0.4
2010Dec 31, 201039.9×–

More Lifecore Biomedical figures

See a number that looks wrong?